54 results

• Gilead Settles HIV Drug Lawsuit Over Patent on Truvada and Descovy

  January 20, 2025

  Irvin Jackson

  The U.S. and Gilead have reached a settlement agreement involving patent rights to two HIV drugs, Truvada and Descovy, which are used as pre-exposure prophylaxis treatments to prevent the spread of HIV.

• Gilead Claims Twice-Annual Injection Better At Preventing HIV Than Daily PrEP Pill

  September 23, 2024

  Irvin Jackson

  Drug maker says twice-yearly injection could be more effective at preventing HIV infections than Truvada, which is a daily PrEP pill that has been linked to reports of kidney injuries, bone fractures and other concerns.

• U.S. Government Files Appeal Over Gilead Truvada, Descovy HIV Drug Patents

  July 10, 2024

  Irvin Jackson

  The U.S. government has asked a federal appeals court to overturn a 2023 jury verdict, which rejected claims that Gilead illegally profited from its patent on certain HIV drugs that the CDC helped the manufacturer develop.

• Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M

  June 12, 2024

  Irvin Jackson

  Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.

• TDF Lawsuit Filed Against Gilead Over Toxic Side Effects of Truvada, Atripla, Other HIV Drugs

  March 27, 2024

  Irvin Jackson

  A TDF lawsuit filed by 26 plaintiffs claims Gilead purposefully exposed them to increased kidney disease and bone fracture risks from its older HIV drugs to increase profits.

• Lawsuits Over Truvada, Other TDF-Based HIV Drugs Cleared To Move Forward By Appeals Court

  January 12, 2024

  Irvin Jackson

  A California appeals court has cleared the way for 24,000 lawsuits over Truvada and other TDF-based Gilead HIV drugs to proceed on claims of negligence.

• Appeals Court Weighs Gilead Challenge to Lawsuits Over Delaying HIV Drug Development

  September 5, 2023

  Irvin Jackson

  A California appeals court is weighing whether Gilead had a responsibility to develop safer HIV drugs to replace older ones with a higher risk of kidney damage and bone fractures.

• U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention

  August 24, 2023

  Irvin Jackson

  A federal task force is recommending widespread use of Gilead HIV drugs as preventative measures to those at high risk of exposure.

• Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva

  July 10, 2023

  Irvin Jackson

  Gilead and Teva are not liable for antitrust violations which insurers and other drug purchasers said was a "pay-to-delay" scheme designed to illegally maximize the manufacturers' profits.

• Lawsuit Against Truvada, Viread Maker Alleges TDF-Based HIV Drugs Toxic to Users Kidneys, Bones

  June 6, 2023

  Irvin Jackson

  Nearly 20 plaintiffs have filed a lawsuit against Gilead, saying it failed to warn patients its TDF-based HIV drugs could cause bone and kidney problems.